BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 21753175)

  • 1. Brain perfusion patterns in familial frontotemporal lobar degeneration.
    Seelaar H; Papma JM; Garraux G; de Koning I; Reijs AE; Valkema R; Rozemuller AJ; Salmon E; van Swieten JC
    Neurology; 2011 Jul; 77(4):384-92. PubMed ID: 21753175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroimaging signature of frontotemporal lobar degeneration associated with Granulin mutations: an effective connectivity study.
    Premi E; Grassi M; Gazzina S; Paghera B; Pepe D; Archetti S; Padovani A; Borroni B
    J Nucl Med; 2013 Jul; 54(7):1066-71. PubMed ID: 23687363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal Lobar Degeneration.
    Premi E; Padovani A; Borroni B
    Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.
    Robinson AC; Thompson JC; Weedon L; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):844-54. PubMed ID: 24861427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
    Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
    JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Martinez-Lage M; Sleiman PM; Hu W; Greene R; Wood EM; Bing S; Grossman M; Schellenberg GD; Hatanpaa KJ; Weiner MF; White CL; Brooks WS; Halliday GM; Kril JJ; Gearing M; Beach TG; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Pickering-Brown SM; Snowden J; van Swieten JC; Heutink P; Seelaar H; Murrell JR; Ghetti B; Spina S; Grafman J; Kaye JA; Woltjer RL; Mesulam M; Bigio E; Lladó A; Miller BL; Alzualde A; Moreno F; Rohrer JD; Mackenzie IR; Feldman HH; Hamilton RL; Cruts M; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bird TD; Cairns NJ; Goate A; Frosch MP; Riederer PF; Bogdanovic N; Lee VM; Trojanowski JQ; Van Deerlin VM
    Arch Neurol; 2011 Apr; 68(4):488-97. PubMed ID: 21482928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct genetic forms of frontotemporal dementia.
    Seelaar H; Kamphorst W; Rosso SM; Azmani A; Masdjedi R; de Koning I; Maat-Kievit JA; Anar B; Donker Kaat L; Breedveld GJ; Dooijes D; Rozemuller JM; Bronner IF; Rizzu P; van Swieten JC
    Neurology; 2008 Oct; 71(16):1220-6. PubMed ID: 18703462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heritability and genetics of frontotemporal lobar degeneration.
    Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN
    Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations.
    Pickering-Brown SM; Rollinson S; Du Plessis D; Morrison KE; Varma A; Richardson AM; Neary D; Snowden JS; Mann DM
    Brain; 2008 Mar; 131(Pt 3):721-31. PubMed ID: 18192287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative study of the neuropathology of 32 sporadic and familial cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).
    Armstrong RA; Carter D; Cairns NJ
    Neuropathol Appl Neurobiol; 2012 Feb; 38(1):25-38. PubMed ID: 21696412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal lobar degeneration: diversity of FTLD lesions.
    Seilhean D; Bielle F; Plu I; Duyckaerts C
    Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration.
    Davidson YS; Robinson AC; Flood L; Rollinson S; Benson BC; Asi YT; Richardson A; Jones M; Snowden JS; Pickering-Brown S; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Jun; 5(1):54. PubMed ID: 28666471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment].
    Rosenmann H; Meiner Z
    Harefuah; 2013 Nov; 152(11):661-6, 687. PubMed ID: 24416825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm.
    Le Ber I
    Rev Neurol (Paris); 2013 Oct; 169(10):811-9. PubMed ID: 24011980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nature versus nurture in frontotemporal lobar degeneration: the interaction of genetic background and education on brain damage.
    Premi E; Garibotto V; Alberici A; Paghera B; Giubbini R; Padovani A; Borroni B
    Dement Geriatr Cogn Disord; 2012; 33(6):372-8. PubMed ID: 22797130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.
    King A; Al-Sarraj S; Troakes C; Smith BN; Maekawa S; Iovino M; Spillantini MG; Shaw CE
    Acta Neuropathol; 2013 Feb; 125(2):303-10. PubMed ID: 23053136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Xiao J; Geser F; Martinez-Lage M; Grossman M; Unger T; Wood EM; Van Deerlin VM; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2010 Jan; 119(1):111-22. PubMed ID: 19649643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
    Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
    J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.